Skip to main content
Clinical Trials/CTRI/2023/09/057901
CTRI/2023/09/057901
Not yet recruiting
Phase 2

A comparative study of safety and efficacy of topical Metformin lotion versus Zinc oxide cream in the treatment of melasma - NI

ITHYAMS0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: L811- Chloasma
Sponsor
ITHYAMS
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
ITHYAMS

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients of both genders above 18 years who were clinically diagnosed to have melasma
  • 2\.Patients willing to give a written informed consent

Exclusion Criteria

  • Before starting the study
  • 1\.Pregnant \& lactating mothers
  • 2\.Patients on oral contraceptives, phenytoin
  • 3\.Patients with unrealistic expectations
  • 4\.Patients who are allergic to metformin
  • 5\.Patients on medications for melasma since at least 2 weeks for topical therapy, 1 month for systemic steroids, 3 months for cosmetic procedures such as laser, dermabrasion, or peels
  • 6\.Patients with co\-morbidities\-DM, SHTN, TB,CAD,EPILEPSY,BA, carcinomas, Renal dysfunction,
  • During Study
  • 1\.If patient develops side effects during the treatment
  • 2\.If patient wants alternate treatment during the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials